chartexchange

Xeris Biopharma Holdings Inc (XERS) (Q3 2026) Earnings Call Highlights: Revenue Surges 44% as ...

GuruFocus | Nov 6, 2026 4:08 PM EST

Xeris Biopharma Holdings Inc (XERS) posted record quarterly revenue of $107.2 million on Recorlev's 93% growth, raised full-year guidance, and lifted its 2030 revenue target to more than $1 billion. Related Stocks: XERS ,

Read original article